PharmaNet Development Group, a provider of clinical development services, has named Joel Posener, M.D., Executive Medical Director, Neuroscience.
Dr. Posener will support PharmaNet project teams conducting clinical trials in psychiatry and neurology and provide drug development advice to clients in neuroscience.
Previously, Dr. Posener held roles at Wyeth as senior director, neuroscience medical research and senior director, early development and clinical pharmacology. He directed phase II projects in psychiatric indications including cognitive impairment in schizophrenia, bipolar disorder and depression. Dr. Posener has also managed early clinical development programs in schizophrenia, depression and Alzheimer's disease.
Before joining the pharmaceutical industry, Dr. Posener served on the faculty of Harvard Medical School and Washington University School of Medicine in St. Louis, where he was also medical director of Metropolitan St. Louis Psychiatric Center. Dr. Posener currently holds an appointment as Clinical Associate Professor of Psychiatry at Temple University School of Medicine.